Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2020. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3951806011 | Nintedanib esilate (substance) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3951807019 | Nintedanib esilate | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Nintedanib esilate (substance) | Is a | Enzyme inhibitor | false | Inferred relationship | Some | ||
| Nintedanib esilate (substance) | Is a | Piperazine derivative | true | Inferred relationship | Some | ||
| Nintedanib esilate (substance) | Has disposition (attribute) | Protein kinase inhibitor (disposition) | true | Inferred relationship | Some | ||
| Nintedanib esilate (substance) | Is modification of (attribute) | Nintedanib (substance) | true | Inferred relationship | Some | ||
| Nintedanib esilate (substance) | Is a | Antineoplastic agent (substance) | true | Inferred relationship | Some | ||
| Nintedanib esilate (substance) | Is a | Protein kinase inhibitor | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing precisely nintedanib (as nintedanib esilate) 150 milligram/1 each conventional release oral capsule (clinical drug) | Has precise active ingredient | True | Nintedanib esilate (substance) | Inferred relationship | Some | 1 |
| Nintedanib (as nintedanib esilate) 100 mg oral capsule | Has precise active ingredient | True | Nintedanib esilate (substance) | Inferred relationship | Some | 1 |
Reference Sets
Belgian subset for AllergyIntolerance, causative agent, drug
FHIR